GLCUX
Price
$36.60
Change
+$0.31 (+0.85%)
Updated
Sep 11 closing price
Net Assets
1.62B
VIGAX
Price
$271.83
Change
+$2.43 (+0.90%)
Updated
Sep 11 closing price
Net Assets
384.53B
Interact to see
Advertisement

GLCUX vs VIGAX

GLCUX vs VIGAX Comparison Chart in %
View a ticker or compare two or three
VS
GLCUX vs. VIGAX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLCUX is a Buy and VIGAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGAX has more cash in the bank: 385B vs. GLCUX (1.62B). VIGAX pays higher dividends than GLCUX: VIGAX (0.37) vs GLCUX (0.00). GLCUX was incepted earlier than VIGAX: GLCUX (11 years) vs VIGAX (26 years). GLCUX (0.56) is less costly to investors than VIGAX (0.05). GLCUX is a more actively managed with annual turnover of: 209.00 vs. VIGAX (12.00). VIGAX has a lower initial minimum investment than GLCUX: VIGAX (3000) vs GLCUX (5000000). VIGAX annual gain was more profitable for investors over the last year : 11.38 vs. GLCUX (-4.98). VIGAX return over 5 years is better than : 71.94 vs. GLCUX (-26.25).
GLCUXVIGAXGLCUX / VIGAX
Total Expense Ratio0.530.051,060%
Annual Report Gross Expense Ratio0.560.051,120%
Fund Existence11 years26 years-
Gain YTD-0.6577.271-9%
Front LoadN/AN/A-
Min. Initial Investment50000003000166,667%
Min. Initial Investment IRAN/AN/A-
Net Assets1.62B385B0%
Annual Yield % from dividends0.000.37-
Returns for 1 year-4.9811.38-44%
Returns for 3 years32.8683.3039%
Returns for 5 years-26.2571.94-36%
Returns for 10 years55.83378.8815%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VNSAX24.180.32
+1.34%
Natixis Vaughan Nelson Select A
FAOOX68.560.35
+0.51%
American Funds Invmt Co of Amer 529-F-3
JLVRX23.78N/A
N/A
JPMorgan Large Cap Value R5
PJHRX35.00N/A
N/A
PGIM Jennison Health Sciences R
NELCX57.46N/A
N/A
Nuveen Equity Long/Short C